New gout drug shows promise in lowering uric acid levels
NCT ID NCT03934099
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new medicine called LC350189 in 156 adults with gout and high uric acid. The goal was to see if different doses could safely lower uric acid below target levels over 12 weeks. Participants took the drug or a placebo, and researchers measured uric acid in the blood at several time points.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advanced Clinical Research
West Jordan, Utah, 84088, United States
-
Altoona Center For Clinical Research
Duncansville, Pennsylvania, 16635, United States
-
Avant Research Associates
Austin, Texas, 78704, United States
-
Avita Clinical Trials
Tampa, Florida, 33613, United States
-
Clinical Research Trials of Florida, Inc
Tampa, Florida, 33607, United States
-
Discovery MM Services Incorporated
Houston, Texas, 77450, United States
-
Dominion Medical Associates
Richmond, Virginia, 23219, United States
-
Health Awareness Inc
Jupiter, Florida, 33458, United States
-
IACT Health
Columbus, Georgia, 31904, United States
-
Meridien Research
Maitland, Florida, 32751, United States
-
Meridien Research
St. Petersburg, Florida, 33709, United States
-
Miami Dade Medical Research Institute
Miami, Florida, 33176, United States
-
Olive Branch Family Medical Cente
Olive Branch, Mississippi, 38654, United States
-
OnSite Clinical Solutions
Charlotte, North Carolina, 28226, United States
-
OnSite Clinical Solutions
Charlotte, North Carolina, 28277, United States
-
Paramount Medical Research and Consulting
Middleburg Heights, Ohio, 44130, United States
-
Preferred Research Partner
Little Rock, Arkansas, 72211, United States
-
Quality Clinical Research
Omaha, Nebraska, 68114, United States
-
Synexus Clinical Research
Birmingham, Alabama, 35211, United States
-
Synexus Clinical Research
Chandler, Arizona, 85224, United States
-
Synexus Clinical Research
Mesa, Arizona, 85206, United States
-
Synexus Clinical Research
Tucson, Arizona, 85712, United States
-
Synexus Clinical Research
Chicago, Illinois, 60602, United States
-
Synexus Clinical Research
Richfield, Minnesota, 55423, United States
-
Synexus Clinical Research
St Louis, Missouri, 63141, United States
-
Synexus Clinical Research
Omaha, Nebraska, 68144, United States
-
Synexus Clinical Research
Henderson, Nevada, 89052, United States
-
Synexus Clinical Research
Akron, Ohio, 44311, United States
-
Synexus Clinical Research
Cincinnati, Ohio, 45236, United States
-
Synexus Clinical Research
Columbus, Ohio, 43212, United States
-
Synexus Clinical Research
Anderson, South Carolina, 29621, United States
-
Synexus Clinical Research
Dallas, Texas, 75234, United States
-
Synexus Clinical Research
San Antonio, Texas, 78229, United States
-
Synexus Clinical Research
Salt Lake City, Utah, 84123, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection tame Gout's uric acid?
- One infusion, two targets: a uric-acid-lowering drug takes aim at heart and kidney disease in youth-onset diabetes
- Can an ancient herbal formula tame gout?
- New drug combo aims to tame stubborn gout flares
- Timing matters: study tests if starting gout drug during a flare is safe
- Gum disease link to high uric acid under microscope